June 25, 2009 — As of mid-2009, The Michael J. Fox Foundation for Parkinson’s Research has already funded over $1 million in high-risk, high-reward approaches to Parkinson’s therapeutic development through its groundbreaking Rapid Response Innovation Awards. Projects include investigations of the safety and efficacy of an FDA-approved drug for kidney disease to treat Parkinson’s; characterization of a tenuous link between PD and certain strains of influenza virus; and a proof-of-principle approach to refine deep brain stimulation (DBS) into a potentially more effective symptomatic therapy.
The NonProfit Voice Ep 14: Navigating and Fundraising Through a Global Crisis
Nonprofit Marketing Trends to Help You Prioritize
Webinar: How Helping Your Donors Can Help You
Nonprofits Are Working Smarter to Grow Peer-to-Peer Fundraising Programs
A Story of a Woman Who Defied All Odds and Is Now Bringing Education to Girls Globally
Podcast: Top 40 Nonprofit Trends for 2020